1. Home
  2. CRL vs HALO Comparison

CRL vs HALO Comparison

Compare CRL & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$169.58

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$63.60

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRL
HALO
Founded
1947
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
8.8B
IPO Year
1999
2001

Fundamental Metrics

Financial Performance
Metric
CRL
HALO
Price
$169.58
$63.60
Analyst Decision
Buy
Buy
Analyst Count
12
11
Target Price
$200.09
$78.18
AVG Volume (30 Days)
761.0K
1.3M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.56
Revenue
$1,857,601,000.00
$151,862,000.00
Revenue This Year
$0.99
$28.24
Revenue Next Year
$3.26
$12.79
P/E Ratio
N/A
$24.64
Revenue Growth
10.48
N/A
52 Week Low
$91.86
$47.50
52 Week High
$228.88
$82.22

Technical Indicators

Market Signals
Indicator
CRL
HALO
Relative Strength Index (RSI) 51.91 43.61
Support Level $166.86 $61.28
Resistance Level $182.76 $65.40
Average True Range (ATR) 7.16 1.64
MACD 2.31 0.41
Stochastic Oscillator 66.74 53.58

Price Performance

Historical Comparison
CRL
HALO

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: